An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis

Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1) inhibitors are an innovative and futuristic orally active group of antituberculosis agents. A few DprE1 inhibitors are in the clinical trial for tuberculosis (TB), including macozinone. This review highlights the discovery, developmental status,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mohd. Imran (Author), Shah Alam Khan (Author), Syed Mohammed Basheeruddin Asdaq (Author), Mazen Almehmadi (Author), Osama Abdulaziz (Author), Mehnaz Kamal (Author), Mohammed Kanan Alshammari (Author), Lojain Ibrahim Alsubaihi (Author), Khansa Hamza Hussain (Author), Abrar Saleh Alharbi (Author), A. Khuzaim Alzahrani (Author)
Formato: Livro
Publicado em: Elsevier, 2022-10-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível